Additional file 1: Table S1. of Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Summary of seven patient deaths. (PDF 14 kb)